PROJECT STAGE
Therapeutic area
Inflammation
Background info
Indication
Advantages
Intellectual property
Owner/lead
Project Aim
To develop small molecule inhibitors of MIF for the treatment of inflammatory diseases
Advantage
Lead series with more desirable chemical properties than those previously disclosed from competitor MIF programmes
Target Class
Inflammatory Cytokine
Modality
Small molecule
Current Status
Lead optimisation with in-vivo proof of concept planned
Intellectual Property
Opportunity to create a protective IPR portfolio
Offering
Licence